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Abstract
Rewarding and aversive stimuli evoke very different patterns of behavior and are rapidly
discriminated. Here taste stimuli of opposite hedonic valence evoked opposite patterns of
dopamine and metabolic activity within milliseconds in the nucleus accumbens. This rapid
encoding may serve to guide ongoing behavioral responses and promote plastic changes in
underlying circuitry.
Rewards and punishments powerfully shape our behavior. The nucleus accumbens (NAc)
integrates sensory and emotional information to guide motor output, and dopamine release
in the NAc is thought to promote reward-related learning1 and behavioral responses to
incentive stimuli2. It is controversial whether dopamine release in the NAc exclusively
signals aspects of reward or serves a more broad purpose for signaling novelty or salience
regardless of hedonic value3. Imaging studies have shown increased activity in the NAc in
response to both stimuli of differing salience and hedonic valence4. In contrast, electro-
physiological evidence has shown differential responding of individual NAc neurons to
rewarding and aversive stimuli5 and has shown that aversive, noxious stimuli evoke pauses
in the firing rate of dopamine neurons in anesthetized rats6,7 and behaving primates8.
To dissociate salience or novelty from hedonic valence, we delivered brief intra-oral
infusions of sucrose and quinine solutions to naive behaving rats and measured changes in
dopamine concentration and pH in the NAc (Supplementary Fig. 1 online) every 100 ms
using fast-scan cyclic voltammetry (see Supplementary Methods online). The pH
measurements provide a measure of metabolic activity9 and thus an indirect measure of
general neuronal activity. Appetitive (0.3 M sucrose) and aversive (0.001 M quinine) stimuli
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were delivered intra-orally to ensure equal exposure and transduction via the same sensory
modality: the taste system. Each animal received both appetitive and aversive stimuli at
unpredictable times to ensure comparable novelty and salience but opposing hedonic
valence. This design elicited strong and consistent behavioral differences in hedonic
expression with no evidence of anticipatory or conditioned responses (Supplementary Fig. 2
online). Voltammetric recordings permitted real-time detection of dopamine release and
NAc activity, elucidating their role in signaling hedonic valence.
Although dopamine release events (transients) and pH changes were apparent on individual
trials of both hedonic stimuli (see Supplementary Figs. 3 and 4 online), their frequency and
magnitude greatly differed during and in the seconds after the intra-oral infusions. We
compared dopamine concentration and pH changes in response to sucrose and quinine
infusions averaged across sessions (Fig. 1). The average dopamine concentration in the
seconds before infusion onset did not differ between sucrose and quinine trials (21.4 ± 0.26
nM versus 19.3 ± 0.27 nM for sucrose versus quinine, respectively; Tukey’s test, P = 0.19).
Intra-oral sucrose infusions evoked a significant rise in dopamine concentration that
persisted throughout the post-infusion period (peak dopamine concentration at 4.4 s after
infusion onset, 44.0 ± 13 nM, mean ± s.e.m., Tukey’s test, P < 0.001; Fig. 1c). In the quinine
sessions (Fig. 1c), dopamine was significantly decreased during the infusion and post-
infusion epochs relative to its own baseline (minimum at 1.7 s after infusion onset, 0.00 ± 5
nM, mean ± s.e.m., Tukey’s test, P < 0.001). The observed changes in dopamine
concentration were significantly different between sucrose and quinine infusions (F =
238.33, P < 0.001). The decrease in dopamine concentration that we observed during
quinine infusions could result from negative prediction error in rats that had previously
experienced sucrose infusions. However, it is important to note that decreases in dopamine
concentration in response to quinine were apparent and no different in naive rats receiving
quinine infusions in comparison to rats that had received a block of sucrose before quinine
infusions (Supplementary Figs. 5 and 6 online).
Sucrose and quinine infusions also evoked different metabolic activity in the NAc. Again,
the baseline pH measurements did not differ in the seconds preceding sucrose and quinine
delivery (Tukey’s test, P = 0.22). For the sucrose session (Fig. 1d), pH dropped significantly
during the infusion and through 10 s following infusion onset relative to baseline (nadir at
3.6 s after infusion onset, −0.01 ± 0.006 pH units, mean ± s.e.m., Tukey’s test, P < 0.001).
pH values then rose and were significantly greater, relative to baseline, through the rest of
the post-infusion period (peak at 30 s after infusion onset, 0.03 ± 0.011 pH units, mean ±
s.e.m.). For the quinine session (Fig. 1d), pH was significantly higher during all epochs
(infusion and 10, 20 and 30 s post-infusion) following infusion onset relative to baseline
(peak at 23.2 s after infusion onset, 0.03 ± 0.015 pH units, mean ± s.e.m., Tukey’s test, P <
0.001). Finally, a comparison of the two stimuli revealed that pH during sucrose trials was
significantly lower than that during quinine trials for the infusion and post-infusion epochs
(F = 146.33, P < 0.001).
Spontaneous dopamine transients were clearly observed during all epochs on individual
sucrose trials and the baseline and post-infusion epochs on quinine trials (see Supplementary
Figs. 3 and 4 for examples). Although individual release events were typically large (up to
75–100 nM) and brief, the average change in dopamine concentration across trials was
closer to ~20 nM, as a result of averaging of release events that were poorly time-locked to
trial events. To quantify change in the likelihood of individual release events in response to
sucrose and quinine infusions, we evaluated dopamine concentration at every 100-ms time
point of each trial to determine whether it exceeded 40 nM. This value was chosen because
previous reports from our laboratory have found that the average magnitude of dopamine
release events is ~40 nM10. We specifically compared the probability of 40 nM dopamine
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(Prob40) during the baseline and infusion epochs for sucrose and quinine sessions (Fig. 2).
Baseline Prob40 did not differ between sucrose and quinine sessions (0.19 ± 0.09 versus 0.17
± 0.09 for sucrose versus quinine, respectively, mean ± s.e.m., Tukey’s test, P = 0.16). On
sucrose trials, Prob40 increased to 0.39 ± 0.2 during the infusion epoch, whereas on quinine
trials, Prob40 decreased to 0.11 ± 0.1 during the infusion epoch. Differences in Prob40 during
the infusion epochs for sucrose and quinine were significantly different (F = 397.03, P <
0.001). In awake and behaving primates, rewarding food stimuli evoke increases in the
firing rate of presumed dopamine-releasing neurons with short latency11. We found that the
likelihood of high concentration dopamine was increased in response to the intra-oral
infusion of sucrose within the first 500 ms of the intra-oral infusion (0.29 ± 0.04 versus 0.19
± 0.02 for infusion versus baseline, respectively, mean ± s.e.m., P < 0.05).
Appropriate behavioral output demands that animals rapidly discriminate between stimuli on
the basis of hedonic valence. Our results reveal two chemical signals that are involved in
this process, dopamine and pH. Dopamine release events and pH levels were equivalent
during the baseline periods of sucrose and quinine sessions. Not surprisingly, dopamine
concentration increased during and after novel, rewarding sucrose infusions. However,
dopamine release events were strongly suppressed during the 4-s intra-oral infusion of
quinine. pH changes were also differentially modulated by appetitive and aversive stimuli.
Consistent with a recent hypothesis that differential NAc activity reflects appetitive and
aversive states12, the majority of NAc neurons respond to appetitive taste stimuli with
decreases in firing rate and to aversive taste stimuli with increases in firing rate5,13. The pH
measurements that we report here may reflect this differential population activity and
suggests a functional link between the two measures. Thus, dopamine signaling and general
activity in the NAc is exquisitely sensitive to both rewarding and aversive taste stimuli. In
addition, given that intra-oral infusions were unexpected, the data are consistent with the
reward prediction error hypothesis of dopamine signaling8,11. The chemical signaling that
we observed here may serve to bias motor output toward ingestion or rejection.
Alternatively, through precise timing, they may serve to guide future behavior by
influencing plastic changes in the NAc14,15. Robust chemical signaling in the NAc encodes
information about biologically salient stimuli. However, even when stimuli are equated for
novelty, duration of exposure, route of administration and salience, rewarding and aversive
stimuli evoke clearly dissociable patterns of chemical signaling.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors wish to thank M.L.A.V. Heien for programming assistance, S. Ng-Evans and S.A. Wescott for
technical assistance, and B.J. Aragona for review of this manuscript. This work was supported by US National
Institute on Drug Abuse grants (DA018298 to M.F.R., DA10900 to R.M.W. and DA17318 to R.M.C.).
References
1. Waelti P, Dickinson A, Schultz W. Nature. 2001; 412:43–48. [PubMed: 11452299]
2. Berridge KC, Robinson TE. Trends Neurosci. 2003; 26:507–513. [PubMed: 12948663]
3. Ungless MA. Trends Neurosci. 2004; 27:702–706. [PubMed: 15541509]
4. Cooper JC, Knutson B. Neuroimage. 2008; 39:538–547. [PubMed: 17904386]
5. Roitman MF, Wheeler RA, Carelli RM. Neuron. 2005; 45:587–597. [PubMed: 15721244]
6. Ungless MA, Magill PJ, Bolam JP. Science. 2004; 303:2040–2042. [PubMed: 15044807]
Roitman et al. Page 3













7. Coizet V, Dommett EJ, Redgrave P, Overton PG. Neuroscience. 2006; 139:1479–1493. [PubMed:
16516396]
8. Mirenowicz J, Schultz W. Nature. 1996; 379:449–451. [PubMed: 8559249]
9. Venton BJ, Michael DJ, Wightman RM. J Neurochem. 2003; 84:373–381. [PubMed: 12558999]
10. Stuber GD, Roitman MF, Phillips PE, Carelli RM, Wightman RM. Neuropsychopharmacology.
2005; 30:853–863. [PubMed: 15549053]
11. Schultz W. J Neurophysiol. 1998; 80:1–27. [PubMed: 9658025]
12. Carlezon WA Jr, Thomas MJ. Neuropharmacology. July 15.2008 published online. 10.1016/
j.neuropharm.2008.06.075
13. Wheeler RA, et al. Neuron. 2008; 57:774–785. [PubMed: 18341996]
14. Calabresi P, Picconi B, Tozzi A, Di Filippo M. Trends Neurosci. 2007; 30:211–219. [PubMed:
17367873]
15. Arbuthnott GW, Wickens J. Trends Neurosci. 2007; 30:62–69. [PubMed: 17173981]
Roitman et al. Page 4














Average fluctuations in chemical signaling in response to rewarding and aversive taste
stimuli. (a,b) Voltammetric responses to rewarding (a) and aversive (b) stimuli. The color
plots indicate changes in dopamine and pH in response to intra-oral infusions of sucrose
(denoted by red bar). Time is the abscissa, the electrode potential is the ordinate and current
changes are encoded in color. Average dopamine concentration (identified by its oxidation
(~0.6 V) and reduction (~−0.2 V on the negative going scan) features) increased during and
after the infusion. In addition, changes in pH can be seen as multiple, longer lasting peaks,
with a pronounced peak at ~−0.2 V on the positive going scan. (c) Average dopamine
concentration changes for sucrose (mean ± s.e.m. denoted by black solid and broken lines,
respectively) and quinine (red). (d) Average pH changes for sucrose and quinine, shown as
in c.
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Rewarding and aversive taste stimuli differentially modulate the probability of high
increases in dopamine concentration (*P < 0.05 relative to sucrose baseline, **P < 0.05
relative to quinine baseline and ***P < 0.05 relative to sucrose infusion).
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